tirzepatide surmount-1 nejm 2022 weight loss percent A 3-year study of in participants with obesity and prediabetes showed substantial and sustained reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full tirzepatide surmount-1 nejm 2022 weight
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4



























